Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
G.van GemertW
O verweight individuals with a BMI 27 kg/m and at least one weight-related comorbidity (such as hypertension, hyperlipidemia, type 2 diabetes, sleep apnea, etc.)
Injectable options with established authorisation: Semaglutide 2.4 mg (Wegovy) : A once-weekly GLP-1 receptor agonist injection authorised by the MHRA for chronic weight management
However, for people with needle phobia or strong injection aversion, oral semaglutide offers a less effective but viable alternative
US$ 21.17
US$ 22.02
US$ 21.39
US$ 28.39
